Amgen Inc. (AMGN) stock moves up, “Buy” rating reaffirmed by BMO Capital Markets Analysts

Amgen Inc. (NASDAQ: AMGN) shares rose in early trading today on lower trade volume than normal after a number of analysts weighed in on the investing value of the stock and reiterated thier respective ratings.

Meanwhile, U.S. stocks edged lower Monday, with major indexes retreating from record levels.

The Dow Jones Industrial Average DJIA, -0.31% fell 48 points, or 0.2%, to 19,916, while the S&P 500 index SPX, -0.29% lost 5 points to 2,272, a drop of 0.2%. The Nasdaq Composite Index COMP, -0.03% rose 4 points to 5,529, a gain of about 0.1%.

Analysts at BMO Capital Markets reiterated a Buy rating on shares of Amgen Inc. (NASDAQ: AMGN) in a reserach note to investors, making it one of the more closely watched stocks on Wall Street. With a rating of Buy on the stock, the company has a 52-week high of $176.85. As a means of comparison, a number of other analysts have issued reports on the company in recent days, and Amgen Inc. has secured a consensus one-year price target of $181.18, above the opening price of $157.01, a difference of 11.51 percent. Share prices often move to the upside on recommendations and new price targets of professional brokerage firms.

Yesterday Amgen Inc. (NASDAQ: AMGN) shares last traded at $157.35, which is an increase of $0.57 from the previous closing price. Opening at $157.01, they varied from $157.01 and $158.55 throughout the day.

Amgen Inc. (NASDAQ: AMGN) currently has a market cap of 117.06B.

Amgen Inc. (NASDAQ: AMGN) Average Daily Trading Volume

The stock’s average daily volume is 4,050,780 shares out of a total float 742,866,000 and some 704,216 shares traded hands yesterday, 41 percent below the norm. lower than normal. Look for trading volume to pick up in the coming days as investors often use upticks in trading volume to identify heavy volume accumulation or distribution by institutional investors.

However, a single day of heavy buy side trading is not enough to assert a trend. As such, market traders will continue to watch for institutional sponsorship as a signal that financial institutions are moving forward.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Institutional investors such as these retain teams of analysts researching thousands of stocks. So watching their interests is a good way to make sure you are buying the right stocks.

Amgen Inc. (NASDAQ: AMGN) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By tracking the activity of these professional investors—and the moving averages they affect—it allows for traders to make more effective decisions on trades.

With that in mind, Amgen Inc. (NASDAQ: AMGN) now has a 50-day MA of $146.78 and 200-day MA of $159.07. It has traded in a 52-week range between $133.64 – 176.85 and today’s last price is 11.03%% lower than the 52 week high of $176.85.

Indeed, earnings growth is among the most important things to look at in regards to stock investing and, accordingly, investors seek companies that have increased their earnings at least 25% or more over 3 consecutive years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *